Cargando…

Comprehensive Pulmonary Safety Review of Inhaled Technosphere(®) Insulin in Patients with Diabetes Mellitus

BACKGROUND AND OBJECTIVE: Technosphere(®) Insulin (TI), a human insulin powder for inhalation (Afrezza(®); MannKind Corporation, Westlake Village, CA, USA), is an ultra-rapid-acting inhaled insulin indicated to improve postprandial glycemic control in patients with type 1 or type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGill, Janet B., Peters, Anne, Buse, John B., Steiner, Susanne, Tran, Tiffany, Pompilio, Frank M., Kendall, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511468/ https://www.ncbi.nlm.nih.gov/pubmed/32720187 http://dx.doi.org/10.1007/s40261-020-00958-8

Ejemplares similares

Hypoglycaemia is reduced with use of inhaled Technosphere(®) Insulin relative to insulin aspart in type 1 diabetes mellitus
por: Seaquist, E. R., et al.
Publicado: (2019)

Place of technosphere inhaled insulin in treatment of diabetes
por: Mikhail, Nasser
Publicado: (2016)

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
por: Rosenstock, Julio, et al.
Publicado: (2008)

Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus
por: Grant, Marshall, et al.
Publicado: (2021)

A Population Dose–Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects
por: Rüppel, D, et al.
Publicado: (2017)

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin
por: Levin, Philip A, et al.
Publicado: (2016)

Case Report: Efficient Avoidance of Hospitalization for Diabetic Ketosis Utilizing Technosphere Inhaled Insulin
por: Bell, David S. H., et al.
Publicado: (2020)

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
por: Akturk, Halis Kaan, et al.
Publicado: (2018)

Time–Action Profile of Technosphere Insulin in Children with Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2023)

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator
por: Visentin, Roberto, et al.
Publicado: (2016)

Geek and hacker stories: code, culture and storytelling from the technosphere
por: Alleyne, Brian
Publicado: (2018)

Planetary Scale Information Transmission in the Biosphere and Technosphere: Limits and Evolution
por: Lingam, Manasvi, et al.
Publicado: (2023)

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
por: McGill, Janet B.
Publicado: (2014)

Technospheric Mining of Rare Earth Elements from Bauxite Residue (Red Mud): Process Optimization, Kinetic Investigation, and Microwave Pretreatment
por: Reid, Sable, et al.
Publicado: (2017)

Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)
por: Gatto, Nicolle M., et al.
Publicado: (2019)

Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence
por: McGill, Janet B
Publicado: (2010)

Insulin Receptor Autoantibody–mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease
por: Petersen, Max C, et al.
Publicado: (2021)

Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
por: Tobin, G S, et al.
Publicado: (2012)

Faecal Microbiota of Cats with Insulin-Treated Diabetes Mellitus
por: Bell, Erin T., et al.
Publicado: (2014)

Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus
por: Mehta, Rucha J., et al.
Publicado: (2019)

A Review of the Impact of Smoking on Inhaled Insulin: Would You Stop Smoking if Insulin Can Be Inhaled?
por: Malhotra, Parul, et al.
Publicado: (2020)

Inhaled insulin for controlling blood glucose in patients with diabetes
por: Silverman, Bernard L, et al.
Publicado: (2007)

Editorial for July/August Issue of AACE Clinical Case Reports
por: Jasim, Sina, et al.
Publicado: (2023)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
por: Aleppo, Grazia, et al.
Publicado: (2021)

Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the Inhaled Insulin Treatment Questionnaire (IITQ)
por: Rubin, Richard R, et al.
Publicado: (2010)

Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008)

Inhaled insulin: overview of a novel route of insulin administration
por: Mastrandrea, Lucy D
Publicado: (2010)

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
por: D’Urzo, Anthony D, et al.
Publicado: (2015)

Safety assessment of inhaled xylitol in mice and healthy volunteers
por: Durairaj, Lakshmi, et al.
Publicado: (2004)

Fast‐acting insulin aspart versus insulin aspart in the setting of insulin degludec‐treated type 1 diabetes: Efficacy and safety from a randomized double‐blind trial
por: Buse, John B., et al.
Publicado: (2018)

Introduction
por: McGill, Janet
Publicado: (2018)

Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease
por: Tuttle, Katherine R., et al.
Publicado: (2020)

Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations
por: Leahy, John (Jack) L, et al.
Publicado: (2019)

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
por: Rosenstock, J., et al.
Publicado: (2009)

Comparative Analysis of Inhaled Insulin With Other Types in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Khan, Abu baker, et al.
Publicado: (2022)

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
por: Rosenstock, J., et al.
Publicado: (2009)

Comparing the effects of insulin glargine and thiazolidinediones on plasma lipids in type 2 diabetes: a patient-level pooled analysis
por: Chaudhuri, Ajay, et al.
Publicado: (2012)

SAT256 Buschke Loewenstein Tumor Presenting With Hypercalcemia
por: Jones, Kai, et al.
Publicado: (2023)

Inhaled insulin: A “puff” than a “shot” before meals
por: Brashier, Dick B. S., et al.
Publicado: (2015)

Treatment outcomes of using inhalation sedation for comprehensive dental care
por: Madouh, M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j239todbiv5dn6hps19d43cqtp